Concepedia

Lloyd R. Whitfield

LR

Statistics

Publications

31

Citations

1.3K

H-Index

20

Active since

1978

Affiliations

Pfizer (United States)(Current)

Warner University

University at Buffalo, State University of New York

Michigan Medicine

Griffin Hospital

Lloyd R. Whitfield is an author at Pfizer (United States) specializing in pharmacology, pharmacokinetics, and medicine.

Publications per year

1978–2011

31

Publications

31

Atorvastatin Transport in the Caco-2 Cell Model: Contributions of P-Glycoprotein and the Proton-Monocarboxylic Acid Co-Transporter

Xiaochun Wu, Lloyd R. Whitfield, Barbra H. Stewart · Pharmaceutical Research · 2000 · 190 citations

, , +12

Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated Secretion

Rebecca A. Boyd, R. H. Stern, Barbra H. Stewart et al. · The Journal of Clinical Pharmacology · 2000 · 172 citations

, , +9

Pharmacodynamic Effects and Pharmacokinetics of Atorvastatin after Administration to Normocholesterolemic Subjects in the Morning and Evening

Donald D. Cilla, Donald M. Gibson, Lloyd R. Whitfield et al. · The Journal of Clinical Pharmacology · 1996 · 98 citations

, , +16

Effect of Age and Gender on Pharmacokinetics of Atorvastatin in Humans

Donald M. Gibson, Nicola J. Bron, MPhil Alan Richens et al. · The Journal of Clinical Pharmacology · 1996 · 90 citations

, , +14

Effect of Food on the Bioavailability of Atorvastatin, an HMG‐CoA Reductase Inhibitor

Louis L. Radulovic, Donald D. Cilla, Edward L. Posvar et al. · The Journal of Clinical Pharmacology · 1995 · 62 citations

, , +16

1–5 of 31